| Application no. and date | 20701559.5 (espacenet) (Federated) (European Patent Register), 20200120 | | Patent/reg. no. and date | DK/EP 3914620, 20251126 | | Publication date | 20211201 | | Priority no. and date | US 201962795194 P, 20190122 | | EP pub. no. and date |
EP 3914620 20211201 | | Effective date | | | Applicant/owner | Innate Pharma, 117, Avenue de Luminy
13009 Marseille, FR | | Applicant ref. no. | 2041279 | | Inventor | PATUREL, Carine, 411 allée du Bois
69280 Marcy l'Etoile, FR,
ABDELAZIM, Hatem, 538 Rue Paradis
13008 Marseille, FR | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | A61K 31/282 (2006.01) , A61K 31/7068 (2006.01) , A61K 39/395 (2006.01) , A61P 35/00 (2006.01) , A61P 35/02 (2006.01) , C07K 16/28 (2006.01) , G01N 33/53 (2006.01) | | Title | BEHANDLING AF T-CELLELYMFOM | | Int. application no. | EP2020051234 | | Int. publication no. | WO2020152081 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
